Articles |
From the First Department of Internal Medicine, Kobe University School of Medicine, Japan.
Correspondence to Mitsuhiro Yokoyama, MD, First Department of Internal Medicine, Kobe University School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650, Japan.
| Abstract |
|---|
|
|
|---|
Key Words: phospholipids vascular endothelium lysophosphatidylcholine endothelium-derived relaxing factor intracellular calcium
| Introduction |
|---|
|
|
|---|
In endothelial cells, it is generally accepted that a rise in [Ca2+]i is an essential step in the synthesis of EDRF.13 14 15 16 Numerous studies have shown that the agonist-induced increase in [Ca2+]i involves both a transient inositol 1,4,5-triphosphatemediated release of Ca2+ from intracellular stores and a more sustained transmembrane influx of Ca2+ from the extracellular space. We have already reported that LPC inhibits bradykinin-induced phosphoinositide hydrolysis and Ca2+ transients in cultured bovine aortic endothelial cells.17 The limitations of the study are that the cultured endothelial cells may exhibit phenotypic modifications, including receptor and ion channel expression, an intracellular signal-transduction system, and their functions, compared with intact endothelial cells. Furthermore, using intact endothelial cells isolated from rabbits whose physiological processes (eg, intercellular communication) have not been altered by cell isolation and culture cell passages, we simultaneously measured both isometric tension and [Ca2+]i in the intact aortic endothelial cells to investigate the effect of LPC on the receptor agonistevoked rise in endothelial [Ca2+]i in the present study.
| Methods |
|---|
|
|
|---|
2 mm wide were cut and opened. Two types
of muscle strips were prepared: (1) strips with
endothelium and (2) strips in which
endothelium was mechanically removed by rubbing the
intimal surface with a filter paper moistened with PSS of the following
composition (in mmol/L): NaCl 140, KCl 5.4,
CaCl2 1.5, MgCl2 1.0, NaHCO3
23.8, EDTA 0.01, and glucose 5.5, saturated with 95%
O2 and 5% CO2, at 37°C and pH 7.4.
High-K+ solution was made by substituting NaCl with
equimolar KCl. Isometric tension and [Ca2+]i in aortic strips were measured simultaneously as previously described.18 19 The aortic strips were treated with 6 µmol/L fura 2AM in the presence of 0.02% cremophor EL, a noncytotoxic detergent, for 4 to 6 hours at room temperature (20°C to 25°C) under protection from light. The aortic strip was held horizontally on a silicon rubber sheet laid on the quartz bottom of a 5-mL-vol organ bath (37°C) attached to a fluorimeter (CAF-110, Japan Spectroscopic). One end of the strip was pinned to the silicon rubber sheet adventitial side up and another end was connected to a strain-gauge transducer (Orientec) to monitor the isometric tension under a resting tension of 1 g. The fura 2loaded muscle strips were rinsed twice with normal PSS for 15 minutes in the bath. Excitation light (a spot 2 to 3 mm in diameter) was focused on the strip through a slit of the sheet from the bottom of the bath. The light was obtained from a xenon high-pressure lamp (75 W) equipped with a rotating wheel that had 340-nm and 380-nm interference filters. The aortic strip was illuminated alternately at a cycle of 48 Hz with two excitation wavelengths (340 and 380 nm), and fluorescence emitted from the strip was collected into a photomultiplier through a 500-nm filter. The intensity of fluorescence induced by excitation at 340 nm (F340) and that induced by excitation at 380 nm (F380) was measured, and the ratio of these two fluorescence values (F340/F380) was calculated automatically. Fura 2Ca2+ fluorescence was detected from the endothelial surface of the strip with endothelium and from the surface of the smooth muscle layer of the strip without endothelium.
After muscle tension and fluorescence (F340, F380, and F340/F380) stabilized, the tissue was conditioned by application of high K+ (72.7 mmol/L). Then the strips were precontracted with 0.3 µmol/L PE and subsequently relaxed by a cumulative addition of ACh. After washout and equilibration, the strips were preincubated with selected concentrations of PC or LPC for 20 minutes and the contraction-relaxation cycle was repeated. In some experiments, effects of phospholipids on NTG-induced response were examined in the strips with or without endothelium.
In the fura 2unloaded strips, we examined the changes in autofluorescence in a preliminary experiment and confirmed that muscle contraction increased both F340 and F380 and that inasmuch as the increments in these lights were proportional, F340/F380 did not change. Similar results were reported in rat aortic strips.20 Therefore, the influence of autofluorescence on the changes in [Ca2+]i was negligible in the present study. In the aortic strips successfully loaded with fura 2, an increase of [Ca2+]i induced an increase in F340, as well as a decrease in F380, and resulted in an increase in F340/F380. On the other hand, the insufficient fura 2 loading or the movement of the muscle strip did not change F340 and F380 in mirror image. To distinguish the fura 2Ca2+ signal from autofluorescence or movement artifact, F340 and F380 were always monitored. Only those preparations in which F340 and F380 changed in mirror image were used in the present study.
We measured muscle tension and F340/F380 at a level of their sustained phase in each dose of relaxant agents. The absolute [Ca2+]i was calculated from the equation [Ca2+]i=Kdx(R-Rmin)/(Rmax -R)xs.21 Kd, the dissociation constant of the Ca2+fura 2 complex, was assumed to be 224 nmol/L; R represents the experimentally determined F340/F380. Rmax and Rmin were measured in the presence of 2 µmol/L bromo-A23187, the nonfluorescent Ca2+ ionophore, and 5 mmol/L EGTA, respectively. The constant value s is the ratio of F380 of the tissue measured in Ca2+-free solution to that measured in Ca2+-containing solution in the presence of bromo-A23187. Relaxation values and NTG-induced [Ca2+]i were expressed as percent decreases of the PE (0.3 µmol/L)-induced response. ACh (3 µmol/L)-induced [Ca2+]i was expressed as percent values of that before treatment with phospholipids.
Data Analysis and Statistics
Data were expressed as mean±SEM. Comparisons of means were made
by using the Student's t test for unpaired samples; when
more than two means were compared, ANOVA and the Bonferroni test for
samples were used. A value of P<.05 was considered
statistically significant.
Drugs
The following drugs were used: 1-palmitoyl-2-oleoyl-PC,
1-palmitoyl-LPC, 1-PE hydrochloride, ACh chloride, substance P, and
bromo-A23187 (Sigma Chemical Company); NTG (Nihonkayaku); fura 2AM
and EGTA (Dojindo Laboratories); and cremophor EL (Nakarai Chemicals).
PC and LPC, stored in chloroform-methanol mixtures at -20°C, were
dried under a stream of N2 gas, dissolved in distilled
water, and then sonicated just before use. Bromo-A23187 was dissolved
in ethanol to make the stock solution. Maximal ethanol concentration in
the organ bath was 0.02%, which did not induce any changes in vascular
tension and [Ca2+]i. The other drugs were
dissolved in distilled water and then diluted in buffer. All were
expressed as final concentrations.
| Results |
|---|
|
|
|---|
|
|
Effect of Phospholipids on ACh-Induced Relaxation and Increase in
[Ca2+]i in Endothelial Cells
Fig 3
demonstrates typical
recordings of strips with endothelium
preincubated with LPC or PC. We confirmed in the previous observation
that LPC or PC by itself altered neither the resting tension nor
PE-evoked contraction in aortic strips. Reduced relaxation to ACh was
shown in the strips after preincubation with LPC. Fig 4
shows the concentration-response
relations of muscle tension for ACh. The preincubation of strips with
LPC (2, 10, and 20 µmol/L) shifted the curve to the right
and significantly inhibited endothelium-dependent
relaxation to ACh in a dose-dependent manner. In contrast, PC (20
µmol/L) had no effect on relaxation to ACh (Figs 3
and 4
). As
shown in Fig 3
, PC alone induced no increase in
[Ca2+]i in endothelial cells
and LPC (20 µmol/L) by itself slightly increased
[Ca2+]i to 143±8 nmol/L in
endothelial cells. After preincubation with LPC
(20 µmol/L), ACh-evoked rise in
[Ca2+]i was completely abolished. LPC (2, 10,
and 20 µmol/L) dose dependently inhibited increase in
endothelial [Ca2+]i in
response to a maximally effective dose of ACh (3 µmol/L)
(Fig 5
). On the other hand, PC (20
µmol/L) had no effect on ACh-induced increase in
[Ca2+]i in endothelial cells
(Figs 3
and 5
).
|
|
|
Substance P, another endothelium-dependent relaxant, induced Ca2+ transients in endothelial cells simultaneously with relaxation in the strips with endothelium. Substance Pinduced Ca2+ transients in endothelial cells and relaxation were also inhibited by LPC (data not shown).
Effect of LPC on NTG-Induced Relaxation and Decrease in
[Ca2+]i in Smooth Muscle Cells
LPC or PC by itself altered neither the resting tension nor
[Ca2+]i and had no effect on PE-induced
contraction and [Ca2+]i in smooth muscle
cells in aortic strips without endothelium (data not
shown). Fig 6
shows
concentration-response relations for NTG in the strips without
endothelium. LPC did not affect either NTG-induced
endothelium-independent relaxation or decrease in
[Ca2+]i in smooth muscle cells.
|
| Discussion |
|---|
|
|
|---|
Numerous studies have confirmed that vascular
endothelium modulates smooth muscle tone by releasing
EDRF(s).22 23 Several reports demonstrated that the
impaired endothelium-dependent relaxation may play an
important role in the altered regulation of vascular tone in
atherosclerotic arteries.1 2 3 4 We also have reported that
endothelium-dependent relaxation induced by ACh was
impaired in atherosclerotic arteries isolated from Watanabe heritable
hyperlipidemic rabbits and that the impairment was
further increased during the progression of atherosclerotic plaque
formation.5 In atherosclerotic aorta, severalfold
increases in LPC content were demonstrated in nutritionally induced
atherosclerosis.24 Furthermore, ox-LDL has
been shown to be present in atherosclerotic arterial
lesions in humans and rabbits.8 In ox-LDL,
40% of PC
is converted to LPC during full oxidative modification.10
According to these observations, LPC may be an important factor for
impairment of endothelium-dependent relaxation in
atherosclerotic arteries.
Recently, simultaneous measurement of [Ca2+]i with muscle tension has been performed in intact smooth muscle.25 26 27 28 Sato et al18 have measured endothelial and/or smooth muscle [Ca2+]i simultaneously with muscle tension in rat aorta. An advantage of this method is that it enables us to examine intracellular Ca2+ regulation in intact native endothelial cells. In contrast to the case of cultured endothelial cells, cell-surface receptor and signal-transduction systems as well as intercellular communication between endothelial cells and smooth muscle cells remain intact in isolated native endothelial cells without enzymatic or mechanical treatments and culture passages. As another advantage of the present method, the temporal as well as quantitative relationship between [Ca2+]i and vascular function can be examined. In the present experiments it was found that ACh induced additional increases in [Ca2+]i, which preceded the endothelium-dependent relaxation in the strips precontracted with PE. Moreover, we demonstrated that there was a positive correlation between the increase in [Ca2+]i and vascular relaxation. It is possible that ACh-induced increases in endothelial [Ca2+]i obtained from aortic strips with endothelium (which also contain smooth muscle cells) may be underestimated, because ACh decreases [Ca2+]i in smooth muscle cells by EDRF released from endothelium. It may be concluded that the ACh-induced additional increase in [Ca2+]i is due to the increase in endothelial [Ca2+]i and that synthesis of EDRF is regulated by the amount of [Ca2+]i in the endothelial cells.
In the present study, using the strips without endothelium, we confirmed that LPC affected neither resting tension nor NTG-induced endothelium-independent relaxation. Moreover, resting [Ca2+]i and NTG-induced decrease in [Ca2+]i in smooth muscle cells were not affected by LPC. These findings suggest that LPC has no effect on intracellular Ca2+ regulation in smooth muscle cells and susceptibility of smooth muscle in response to nitric oxide as EDRF.
It is known that LPC also has nonspecific detergent-like cytotoxic properties. Because the critical micelle concentration of LPC in a physiological solution is reported to be 40 to 50 µmol/L,29 this inhibitory effect might be due to cell lysis by the detergent actions of LPC micelles on cell membrane. The inhibitory effect of LPC was abolished by washing strips with PSS containing 0.1% bovine serum albumin (data not shown). Therefore, the observed effect of LPC was not due to endothelial cell lysis, and the endothelial cell function may be reversibly altered by LPC.
To the best of our knowledge, the findings of this study are the first direct evidence that the inhibition of receptor-mediated Ca2+ mobilization in endothelial cells is involved in the inhibitory effect of LPC on endothe- lium-dependent relaxation. Recently, Ohara et al30 showed that activation of protein kinase C by LPC leads to increased O2- formation in intact rabbit aorta. Ca2+-independent mechanisms, such as inactivation of EDRF by increased O2-, may play a role in the inhibition of endothelium-dependent relaxation after exposure to LPC. In this study, however, LPC inhibited both the change in endothelial [Ca2+]i and the change in endothelium-dependent relaxation in parallel. This finding indicates that alteration of endothelial Ca2+ regulation may play a main role in the mechanism of LPC-induced impairment of endothelium-dependent vascular relaxation.
The mechanism by which LPC inhibits receptor-mediated Ca2+ mobilization in endothelial cells is unclear, because the precise mechanism of the Ca2+ influx is not fully established. LPC is an amphiphilic compound and alters the cell function, ie, the kinetics of transmembrane ion transport,31 the activities of membrane-bound enzymes,32 33 34 35 ligand-receptor coupling,36 and gene expressions.37 38 39 According to the previous studies, an increase in LPC may alter physical properties of the plasma membrane, such as membrane fluidity and permeability.40 This alteration of membrane fluidity may also displace boundary lipids around integral proteins such as membrane-bound receptors and many G protein effector systems, which might in turn interfere with protein structure and enzymatic activities.41 The inhibitory effect of LPC may possibly result from the direct interaction with the plasma membrane of endothelial cells. We have reported that LPC and ox-LDL inhibit bradykinin-induced inositol 1,4,5-triphosphate formation and intracellular Ca2+ transients in cultured bovine aortic endothelial cells.17 42 Moreover, Flavahan43 has recently suggested that LPC may mediate in part the dysfunction in the endothelial Gi proteindependent pathway. It is possible that an increased incorporation of LPC into plasma membrane of endothelial cells may induce the disruption of the receptor signal-transduction system, leading to the impaired production of EDRF. We confirmed that LPC also inhibited substance Pinduced Ca2+ transients in endothelial cells and relaxation. This observation suggests that the action of LPC is not as a muscarinic receptor antagonist at endothelial cells.
Recent studies have shown that a hyperpolarization caused by the opening of Ca2+-activated K+ channels is part of the endothelial response to various receptor agonists.44 45 46 This hyperpolarization augments the driving force for the potential-dependent Ca2+ influx,47 48 not via voltage-gated Ca2+ channels,45 thereby contributing to the sustained increase in [Ca2+]i. Therefore, depolarization attenuates Ca2+ entry into activated endothelial cells.45 48 It is also possible that LPC may depolarize endothelial cells, leading to the inhibited Ca2+ influx evoked by receptor agonists. The mechanisms of the inhibitory effect of LPC on receptor-mediated Ca2+ mobilization need to be clarified in future studies.
In conclusion, LPC, which accumulates in ox-LDL and atherosclerotic arteries, inhibits receptor-mediated Ca2+ mobilization in intact aortic endothelial cells of isolated arterial strips. This action of LPC may play an important role in the mechanism of LPC-induced impairment of endothelium-dependent vascular relaxation.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received April 30, 1996; accepted October 25, 1996.
| References |
|---|
|
|
|---|
2. Bossaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry P. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest. 1987;79:170-174.
3.
Förstermann U, Mügge A, Alheid U,
Haverich A, Frölich JC. Selective attenuation of
endothelium-mediated vasodilation in atherosclerotic
human coronary arteries. Circ Res. 1988;62:185-190.
4.
Shimokawa H, Vanhoutte PM. Impaired
endothelium-dependent relaxation to aggregating
platelets and related vasoactive substances in porcine
coronary arteries in
hypercholesterolemia and
atherosclerosis. Circ Res. 1989;64:900-914.
5.
Hirata H, Akita H, Yokoyama M, Watanabe Y.
Impaired vasodilatory response to arterial
natriuretic peptide during atherosclerosis
progression. Arterioscler Thromb. 1992;12:99-105.
6.
Vanhoutte PM, Shimokawa H.
Endothelium-derived relaxing factor and
coronary vasospasm. Circulation. 1989;80:1-9.
7. Yokoyama M, Akita H, Hirata K, Usuki S, Fukuzaki H, Itoh H, Maekawa K, Matsuo T. Supersensitivity of isolated coronary artery to ergonovine in a patient with variant angina. Am J Med. 1990;89:507-515.[Medline] [Order article via Infotrieve]
8. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
9.
Steinbrecher UP, Parthasarathy S, Leake DS, Witztum
JL, Steinberg D. Modification of low density lipoprotein by
endothelial cells involves lipid peroxidation and
degradation of low density lipoprotein phospholipids.
Proc Natl Acad Sci U S A. 1984;81:3883-3887.
10. Yokoyama M, Hirata K, Miyake R, Akita H, Ishikawa Y, Fukuzaki H. Lysophosphatidylcholine: essential role in the inhibition of endotheliun-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun. 1990;168:301-308.[Medline] [Order article via Infotrieve]
11.
Matsuda Y, Hirata K, Inoue N, Suematsu M, Kawashima S,
Akita H, Yokoyama M. High-density lipoprotein reverses
inhibitory effect of oxidized low-density lipoprotein on
endothelium-dependent arterial
relaxation. Circ Res. 1993;72:1103-1109.
12. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344:160-162.[Medline] [Order article via Infotrieve]
13. Lopez-Jaramillo P, Gonzalez MC, Palmar RMJ, Moncada S. The crucial role of physiological Ca2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone. Br J Pharmacol. 1990;101:489-493.[Medline] [Order article via Infotrieve]
14. Schilling WP, Elliott SJ. Ca2+ signaling mechanisms of vascular endothelial cells and their role in oxidant-induced endothelial cell dysfunction. Am J Physiol. 1992;262:H1617-H1630.[Abstract]
15.
Himmel HM, Whorton AR, Strauss HC. Intracellular
calcium, currents, and stimulus-response coupling in
endothelial cells. Hypertension. 1993;21:112-127.
16. Busse R, Mulsch A, Fleming I, Hecker M. Mechanisms of nitric oxide release from the vascular endothelium. Circulation. 1993;87(suppl V):V-18-V-25.
17.
Inoue N, Hirata K, Yamada M, Hamamori Y, Matsuda Y,
Akita H, Yokoyama M. Lysophosphatidylcholine inhibits
bradykinin-induced phosphoinositide hydrolysis and
calcium transients in cultured bovine aortic
endothelial cells. Circ Res. 1992;71:1410-1421.
18.
Sato K, Ozaki H, Karaki H. Differential effects
of carbachol on cytosolic calcium levels in vascular
endothelium and smooth muscle. J
Pharmacol Exp Ther. 1990;255:114-119.
19.
Miwa Y, Hirata K, Matsuda Y, Suematsu M, Kawashima S,
Yokoyama M. Augmented receptor-mediated Ca2+
mobilization causes supersensitivity of contractile response to
serotonin in atherosclerotic arteries. Circ
Res. 1994;75:1096-1102.
20.
Sato K, Ozaki H, Karaki H. Changes in cytosolic
calcium level in vascular smooth muscle strip measured
simultaneously with contraction using fluorescent
calcium indicator fura 2. J Pharmacol Exp Ther. 1988;246:294-300.
21.
Grynkiewicz G, Poenie M, Tsien R. A new
generation of Ca2+ indicators with greatly improved
fluorescence properties. J Biol Chem. 1985;260:3440-3450.
22. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.[Medline] [Order article via Infotrieve]
23.
Furchgott RF. Role of
endothelium in response of vascular smooth
muscle. Circ Res. 1983;53:557-573.
24. Portman OW, Alexander M. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J Lipid Res. 1969;10:158-165.[Abstract]
25. Morgan JP, Morgan KG. Vascular smooth muscle: the first re- corded Ca2+ transients. Pflugers Arch. 1982;395:75-77.[Medline] [Order article via Infotrieve]
26. Ozaki H, Sato K, Satoh T, Karaki H. Simultaneous recordings of calcium signals and mechanical activity using fluorescent dye fura 2 in isolated strips of vascular smooth muscle. Jpn J Pharmacol. 1987;45:429-433.[Medline] [Order article via Infotrieve]
27.
Bruschi G, Bruschi ME, Regolisti G, Borghetti A.
Myoplasmic Ca2+-force relationship studied with fura-2
during stimulation of rat aortic smooth muscle. Am J
Physiol. 1988;254:H840-H854.
28.
Himpens B, Somlyo AP. Free-calcium and force
transients during depolarization and pharmacomechanical coupling in
guinea-pig smooth muscle. J Physiol (Lond). 1988;395:507-530.
29. Bergmann SR, Bruce Ferguson T Jr, Sobel BE. Effects of amphiphiles on erythrocytes, coronary arteries, and perfused hearts. Am J Physiol. 1981;240:H229-H237.
30.
Ohara Y, Peterson TE, Zheng B, Kuo JF, Harrison
DG. Lysophosphatidylcholine increases vascular superoxide anion
production via protein kinase C activation.
Arterioscler Thromb. 1994;14:1007-1013.
31. Sedlis SP, Corr PB, Sobel BE, Ahumada GG. Lysophosphatidylcholine potentiates Ca2+ accumulation in rat cardiac myocytes. Am J Physiol. 1983;244:H32-H38.
32.
Shier WT, Baldwin JH, Nilsen-Hamilton M, Hamilton RT,
Thanassi NM. Regulation of guanylate and
adenylate cyclase activities by
lysolecithin. Proc Natl Acad Sci
U S A. 1976;73:1586-1590.
33. Ahumada GG, Bergmann SR, Carlson E, Corr PB, Sobel BE. Augmentation of cyclic AMP content induced by lysophosphatidylcholine in rabbit hearts. Cardiovasc Res. 1979;13:377-382.[Medline] [Order article via Infotrieve]
34. Karli JN, Karikas GA, Hatzipavlou PK, Levis GM, Moulopoulos SN. The inhibition of Na+ and K+ stimulated ATPase activity of rabbit and dog heart sarcolemma by lysophosphatidylcholine. Life Sci. 1979;24:1869-1876.[Medline] [Order article via Infotrieve]
35. Owens K, Kennett FF, Weglicki WB. Effects of fatty acid intermediates on Na+-K+-ATPase activity of cardiac sarcolemma. Am J Physiol. 1982;242:H456-H461.
36. Briggs MM, Lefkowitz RJ. Parallel modulation of catecholamine activation of adenylate cyclase and formation of the high-affinity agonist receptor complex in turkey erythrocyte membranes by temperature and cis-vaccenic acid. Biochemistry. 1980;19:4461-4466.[Medline] [Order article via Infotrieve]
37. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138-1144.
38. Kume N, Gimbrone MA Jr. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest. 1994;93:907-911.
39.
Hirata K, Miki N, Kuroda Y, Sakoda T, Kawashima S,
Yokoyama M. Low concentration of oxidized low-density
lipoprotein and lysophosphatidylcholine upregulate constitutive nitric
oxide synthase mRNA expression in bovine aortic
endothelial cells. Circ Res. 1995;76:958-962.
40.
Fink KL, Gross RW. Modulation of canine
myocardial sarcolemmal membrane fluidity by amphiphilic
compounds. Circ Res. 1984;55:585-594.
41. Weltzien HU. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim Biophys Acta. 1979;559:259-287.[Medline] [Order article via Infotrieve]
42. Hirata K, Akita H, Yokoyama M. Oxidized low density lipoprotein inhibits bradykinin-induced phosphoinositide hydrolysis in cultured bovine aortic endothelial cells. FEBS Lett. 1991;287:181-184.[Medline] [Order article via Infotrieve]
43.
Flavahan NA. Lysophosphatidylcholine modifies G
protein dependent signaling in porcine endothelial
cells. Am J Physiol. 1993;264:H722-H727.
44.
Busse R, Fichtner H, Lückhoff A, Kohlhardt
M. Hyperpolarization and increased free
calcium in acetylcholine-stimulated endothelial
cells. Am J Physiol. 1988;255:H965-H969.
45.
Colden-Stanfield M, Schilling WP, Ritchie AK,
Eskin SG, Navarro LT, Kunze DL. Bradykinin-induced increases in
cytosolic calcium and ionic currents in cultured bovine aortic
endothelial cells. Circ Res. 1987;61:632-640.
46.
Olsen SP, Davies PF, Clapham DE.
Muscarinic-activated K+ current in bovine aortic
endothelial cells. Circ Res. 1988;62:1059-1064.
47. Adams DJ, Barakeh J, Jaskey R, van Breemen C. Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J. 1989;3:2389-2400.[Abstract]
48.
Schilling WP. Effect of membrane
potential on cytosolic calcium of bovine aortic
endothelial cells. Am J
Physiol. 1989;257:H778-H784.
This article has been cited by other articles:
![]() |
H.-i. Chen, S.-L. Kao, M.-H. Tsai, M.-S. Shiao, and C. J. Jen Exercise Training Modulates the Effects of Lipoproteins on Acetylcholine-Induced Endothelial Calcium Signaling in Rat Aortas Experimental Biology and Medicine, March 1, 2009; 234(3): 323 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mehta Lysophosphatidylcholine: an enigmatic lysolipid Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L174 - L175. [Full Text] [PDF] |
||||
![]() |
S. Kawashima and M. Yokoyama Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 998 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chaudhuri, S. M. Colles, D. S. Damron, and L. M. Graham Lysophosphatidylcholine Inhibits Endothelial Cell Migration by Increasing Intracellular Calcium and Activating Calpain Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 218 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Colles and G. M. Chisolm Lysophosphatidylcholine-induced cellular injury in cultured fibroblasts involves oxidative events J. Lipid Res., August 1, 2000; 41(8): 1188 - 1198. [Abstract] [Full Text] |
||||
![]() |
Y. Rikitake, S. Kawashima, T. Yamashita, T. Ueyama, S. Ishido, H. Hotta, K.-i. Hirata, and M. Yokoyama Lysophosphatidylcholine Inhibits Endothelial Cell Migration and Proliferation via Inhibition of the Extracellular Signal-Regulated Kinase Pathway Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1006 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Dart and J. P.F Chin-Dusting Lipids and the endothelium Cardiovasc Res, August 1, 1999; 43(2): 308 - 322. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |